Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Control in Operatively Treated Ankle Fractures
NCT03696199Phase 4Recruiting
- Sponsor
- Lahey Hospital & Medical Center
- Start
- Sep 2020
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine hydrochloride liposomal suspension injection, clonidine and epinephrine in ankle fracture (3 arms), sponsored by Lahey Hospital & Medical Center. Primary endpoint: Oral Narcotics / Morphine Milligram Equivalents given at 72 hours. Started Sep 2020; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionclonidineepinephrine
03
Conditions
ankle fracture
Beyond the preview
Go deeper on NCT03696199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696199.